Browse 24910 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
March 13th, 2023 |
Strengthening an Integrated Comprehensive Approach for HIV Services for Adolescents and Young People through Determined, Resilient, AIDS-Free Mentored and Safe (DREAMS) Program in Zimbabwe under the President's |
Centers for Disease Control CGH |
March 13th, 2023 |
Sustainable, Innovative, and Agile Community and Facility HIV Prevention, Care and Treatment Services for Epidemic Control among all Populations in Zimbabwe under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
April 4th, 2023 |
Supporting Continuous Quality Improvement, Partnerships, and Innovation for Sustained and Responsive Laboratory Systems, Tiered Diagnostic Networks, and Laboratory Data Management under the President's Emergency Plan |
Centers for Disease Control CGH |
March 28th, 2023 |
Technical Assistance to National Entities and Regional Health Bureaus (RHBs) in the Implementation of HIV Programs across Ethiopia under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
March 27th, 2023 |
Enhancing Comprehensive Community-Based and Sustainable HIV/AIDS Key Population (KP) Prevention Services and Treatment Support for KP Living with HIV in the Republic of Zambia under PEPFAR |
Centers for Disease Control CGH |
March 26th, 2023 |
Transitioning and Integrating Laboratory Services for High Quality HIV Diagnosis, Care, Treatment, and Monitoring to the Ministry of Health (MOH) to Sustain Achievement of the 95-95-95 Goals in Zambia under PEPFAR |
Centers for Disease Control CGH |
March 27th, 2023 |
Enhancing the Quality and Reach of Comprehensive and Sustainable HIV/AIDS Prevention Services in the Republic of Zambia under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
March 7th, 2023 |
Provision of Voluntary Medical Male Circumcision (VMMC) for HIV Prevention in the Republic of South Africa under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
March 13th, 2023 |
Scaling-up Sustainable Voluntary Medical Male Circumcision (VMMC) through Improvements in the Availability, Integration, and Quality of HIV Prevention Services in Zimbabwe under the President's Emergency Plan for AIDS |
Centers for Disease Control CGH |
July 28th, 2025 |
Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
January 10th, 2023 |
Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Liquid Biopsy Research Laboratories (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
October 25th, 2025 |
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2025 |
Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
July 5th, 2025 |
Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R01) |
National Institutes of Health |
May 25th, 2025 |
Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R24 Clinical Trials Not Allowed) |
National Institutes of Health |
September 7th, 2025 |
HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
September 5th, 2025 |
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) |
National Institutes of Health |
November 16th, 2022 |
USAID/Bangladesh Request for Information on USAID's Accelerating Reductions in Adolescent Childbearing |
Bangladesh USAID Dhaka |
March 13th, 2023 |
Strengthening Laboratory Systems that Support Diagnosis, Treatment, Prevention, and Management of HIV/AIDS and Related Public Health Diseases in the Republic of South Sudan under the President's Emergency Plan for AIDS |
Centers for Disease Control CGH |
January 6th, 2023 |
Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed) |
National Institutes of Health |
|
January 6th, 2023 |
Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional) |
National Institutes of Health |
January 23rd, 2023 |
Achieving and Sustaining HIV/TB Epidemic Control in the Limpopo Province |
South Africa USAID Pretoria |
January 17th, 2023 |
Achieving and Sustaining HIV/TB Epidemic Control in the KwaZulu-Natal Province Achieving and Sustaining HIV/TB Epidemic Control in the KwaZulu-Natal Province |
South Africa USAID Pretoria |
February 14th, 2023 |
Utilizing Telomere Status to Reveal Molecular Mechanisms Underlying Susceptibility and Resiliency in Response to Environmental Exposures (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
March 15th, 2023 |
Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional) |
National Institutes of Health |
September 25th, 2025 |
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) |
National Institutes of Health |
August 7th, 2025 |
Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed) |
National Institutes of Health |
December 19th, 2022 |
Cooperative Agreements for Certified Community Behavioral Health Clinic Planning Grants |
Substance Abuse and Mental Health Services Adminis |
January 10th, 2023 |
Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional) |
National Institutes of Health |
March 28th, 2025 |
NCMRR Early Career Research Award (R03 Clinical Trial Optional) |
National Institutes of Health |
January 4th, 2023 |
Achieving and Sustaining HIV/TB Epidemic Control in the Eastern Cape Province - Integrated Service Delivery Response |
South Africa USAID Pretoria |
January 7th, 2026 |
Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) |
National Institutes of Health |
September 30th, 2023 |
Africa Regional Services Paris Annual Program Statement: ARS Speaker Program |
Africa Regional Services |
March 29th, 2023 |
Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed) |
National Institutes of Health |
November 22nd, 2024 |
The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) |
National Institutes of Health |
March 14th, 2023 |
AHEAD (Advancing Head and Neck Cancer Early Detection Research) (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
May 25th, 2025 |
Development of Animal Models and Related Biological Materials for Down Syndrome Research (R24 Clinical Trials Not-Allowed) |
National Institutes of Health |
February 14th, 2023 |
BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (R34 Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2023 |
Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06) |
National Institutes of Health |
December 15th, 2022 |
Dual Purpose with Dual Benefit: Research in Biomedicine and Agriculture Using Agriculturally Important Domestic Animal Species (R01) |
National Institutes of Health |